BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ojima H, Fukuda T, Nakajima T, Nagamachi Y. Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas. Jpn J Cancer Res. 1997;88:262-266. [PMID: 9140110 DOI: 10.1111/j.1349-7006.1997.tb00376.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Kerroucha R, Hervieu V, Chambonnière M, Mège-lechevallier F, Poncet G, Boulez J, Tanière P, Scoazec J. Adénocarcinomes de l’estomac et de l’œsophage distal. Annales de Pathologie 2004;24:228-35. [DOI: 10.1016/s0242-6498(04)93957-0] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
2 Chen JN, He D, Tang F, Shao CK. Epstein-Barr virus-associated gastric carcinoma: a newly defined entity. J Clin Gastroenterol. 2012;46:262-271. [PMID: 22392024 DOI: 10.1097/mcg.0b013e318249c4b8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 27] [Article Influence: 5.9] [Reference Citation Analysis]
3 Tavakoli A, Monavari SH, Solaymani Mohammadi F, Kiani SJ, Armat S, Farahmand M. Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis. BMC Cancer 2020;20:493. [PMID: 32487043 DOI: 10.1186/s12885-020-07013-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Ishii H, Gobé G, Kawakubo Y, Sato Y, Ebihara Y. Interrelationship between Epstein-Barr virus infection in gastric carcinomas and the expression of apoptosis-associated proteins: EBV and apoptosis in gastric cancers. Histopathology 2001;38:111-9. [DOI: 10.1046/j.1365-2559.2001.01037.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
5 Alves G, Macrini CM, de Souza Nascimento P, Morais JC, Ornellas AA. Detection and expression of Epstein-Barr Virus (EBV) DNA in tissues from penile tumors in Brazil. Cancer Lett 2004;215:79-82. [PMID: 15374635 DOI: 10.1016/j.canlet.2004.04.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Chang MS, Kim WH, Kim CW, Kim YI. Epstein-Barr virus in gastric carcinomas with lymphoid stroma. Histopathology. 2000;37:309-315. [PMID: 11012737 DOI: 10.1046/j.1365-2559.2000.01014.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
7 Ushiku T, Chong JM, Uozaki H, Hino R, Chang MS, Sudo M, Rani BR, Sakuma K, Nagai H, Fukayama M. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer. 2007;120:60-66. [PMID: 17058198 DOI: 10.1002/ijc.22275] [Cited by in Crossref: 62] [Cited by in F6Publishing: 58] [Article Influence: 4.1] [Reference Citation Analysis]
8 Chapel F, Fabiani B, Davi F, Raphael M, Tepper M, Champault G, Guettier C. Epstein-Barr virus and gastric carcinoma in Western patients: comparison of pathological parameters and p53 expression in EBV-positive and negative tumours. Histopathology. 2000;36:252-261. [PMID: 10692029 DOI: 10.1046/j.1365-2559.2000.00843.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 1.5] [Reference Citation Analysis]
9 Shin JY, Kim JO, Lee SK, Chae HS, Kang JH. LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells. BMC Cancer. 2010;10:425. [PMID: 20704765 DOI: 10.1186/1471-2407-10-425] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
10 Chang MS, Lee HS, Kim CW, Kim YI, Kim WH. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea. Pathol Res Pract. 2001;197:395-400. [PMID: 11432666 DOI: 10.1078/0344-0338-00052] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.0] [Reference Citation Analysis]
11 Takada K. Epstein-Barr virus and gastric carcinoma. Mol Pathol. 2000;53:255-261. [PMID: 11091849 DOI: 10.1136/mp.53.5.255] [Cited by in Crossref: 201] [Cited by in F6Publishing: 182] [Article Influence: 9.1] [Reference Citation Analysis]
12 Han S, Tay JK, Loh CJL, Chu AJM, Yeong JPS, Lim CM, Toh HC. Epstein–Barr Virus Epithelial Cancers—A Comprehensive Understanding to Drive Novel Therapies. Front Immunol 2021;12:734293. [DOI: 10.3389/fimmu.2021.734293] [Reference Citation Analysis]
13 Bittar Z, Fend F, Quintanilla-Martinez L. Lymphoepithelioma-like carcinoma of the stomach: a case report and review of the literature. Diagn Pathol. 2013;8:184. [PMID: 24188515 DOI: 10.1186/1746-1596-8-184] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
14 Blanchet A, Bourgmayer A, Kurtz JE, Mellitzer G, Gaiddon C. Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair. Cancers (Basel) 2021;13:916. [PMID: 33671606 DOI: 10.3390/cancers13040916] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
15 Kim B, Byun SJ, Kim YA, Kim JE, Lee BL, Kim WH, Chang MS. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas. Pathology. 2010;42:58-65. [PMID: 20025482 DOI: 10.3109/00313020903356392] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
16 Kusano M, Toyota M, Suzuki H, Akino K, Aoki F, Fujita M, Hosokawa M, Shinomura Y, Imai K, Tokino T. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus. Cancer. 2006;106:1467-1479. [PMID: 16518809 DOI: 10.1002/cncr.21789] [Cited by in Crossref: 130] [Cited by in F6Publishing: 115] [Article Influence: 8.1] [Reference Citation Analysis]
17 Murphy G, Pfeiffer R, Camargo MC, Rabkin CS. Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology 2009;137:824-33. [PMID: 19445939 DOI: 10.1053/j.gastro.2009.05.001] [Cited by in Crossref: 253] [Cited by in F6Publishing: 231] [Article Influence: 19.5] [Reference Citation Analysis]
18 Li X, Sun ZQ, Jiang XL. Advances in research of Epstein-Barr virus-associated gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2011; 19(32): 3323-3326 [DOI: 10.11569/wcjd.v19.i32.3323] [Reference Citation Analysis]
19 Lee JH, Kim SH, Han SH, An JS, Lee ES, Kim YS. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol. 2009;24:354-365. [PMID: 19335785 DOI: 10.1111/j.1440-1746.2009.05775.x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 141] [Article Influence: 10.8] [Reference Citation Analysis]
20 Kattoor J, Koriyama C, Akiba S, Itoh T, Ding S, Eizuru Y, Abraham EK, Chandralekha B, Amma N, Nair MK. Epstein-Barr virus-associated gastric carcinoma in southern India: A comparison with a large-scale Japanese series. J Med Virol 2002;68:384-9. [DOI: 10.1002/jmv.10215] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
21 Deyrup AT. Epstein-Barr virus-associated epithelial and mesenchymal neoplasms. Hum Pathol 2008;39:473-83. [PMID: 18342658 DOI: 10.1016/j.humpath.2007.10.030] [Cited by in Crossref: 75] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
22 Stadtländer CT, Waterbor JW. Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis. 1999;20:2195-2208. [PMID: 10590210 DOI: 10.1093/carcin/20.12.2195] [Cited by in Crossref: 126] [Cited by in F6Publishing: 117] [Article Influence: 5.7] [Reference Citation Analysis]